Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Autolus Limited
Seagen Inc.
Mayo Clinic
Corvus Pharmaceuticals, Inc.
Fondazione Italiana Linfomi - ETS
Hoffmann-La Roche
Fred Hutchinson Cancer Center
Bristol-Myers Squibb
National Institutes of Health Clinical Center (CC)
SymBio Pharmaceuticals
City of Hope Medical Center
Seagen Inc.
Medical College of Wisconsin
M.D. Anderson Cancer Center
Mayo Clinic
Fudan University